Eosinophilic asthma is a more severe subtype of asthma. Treatment options include inhaled and oral corticosteroids, leukotriene modifiers, and biologics. Eosinophilic asthma is a subtype of asthma ...

Eosinophilic asthma is a severe form of ... can help you achieve the best outcome for the condition. Traditional asthma treatment involves inhaled corticosteroids and a rescue inhaler.

Unfortunately, these drugs don't work for everyone and they ... is already used for the long-term management of eosinophilic ...

Dupilumab is approved to treat other conditions, including asthma ... been diagnosed with eosinophilic esophagitis or aren’t satisfied with your current treatment, you may want to consider ...

The European Medicines Agency will review GSK's request to approve its asthma drug Nucala as an additional treatment for ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

you and your doctor may need to rethink your treatment. The typical daily treatments – like inhaled corticosteroids and inhaled bronchodilators – don’t always work on eosinophilic asthma.

The Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for depemokimab for asthma with type ... had received prior treatment with systemic ...

AstraZeneca is hopping on the pickleball craze for the latest iteration of its Stepping Back Out campaign for asthma treatment Fasenra.

What Drugs Will Be Impacted? Four medications will be impacted by the changes: Fasenra (benralizumab), used to treat adults with eosinophilic asthma. Tezspire (tezepelumab), used in combination ...